Back to Search
Start Over
Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
- Source :
-
Hormones (Athens, Greece) [Hormones (Athens)] 2019 Jun; Vol. 18 (2), pp. 137-139. Date of Electronic Publication: 2018 Oct 19. - Publication Year :
- 2019
-
Abstract
- Pituitary disorders, and especially prolactinomas, are not common among pregnant women, though they tend to occur during a woman's years of fertility. The majority of prolactinoma patients present with infertility and menstruation dysfunction; however, prolactinomas are associated with potentially significant morbidity if they remain unrecognized and untreated. Herein, we survey the role of prolactin and prolactinomas in pregnancy while also outlining the therapeutic approach to prolactinoma during pregnancy. The current literature on the impact of dopamine agonists during pregnancy is also reviewed.
- Subjects :
- Female
Humans
Hyperprolactinemia blood
Hyperprolactinemia complications
Pituitary Neoplasms blood
Pituitary Neoplasms complications
Pregnancy
Pregnancy Complications, Neoplastic blood
Pregnancy Outcome
Prolactin physiology
Prolactinoma blood
Prolactinoma complications
Treatment Outcome
Dopamine Agonists therapeutic use
Pituitary Neoplasms drug therapy
Pregnancy Complications, Neoplastic drug therapy
Prolactin blood
Prolactinoma drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2520-8721
- Volume :
- 18
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Hormones (Athens, Greece)
- Publication Type :
- Academic Journal
- Accession number :
- 30341577
- Full Text :
- https://doi.org/10.1007/s42000-018-0071-z